Beta‐blockers for hypertension

CS Wiysonge, HA Bradley, J Volmink… - Cochrane database …, 2017 - cochranelibrary.com
Background Beta‐blockers refer to a mixed group of drugs with diverse pharmacodynamic
and pharmacokinetic properties. They have shown long‐term beneficial effects on mortality …

Calcium channel blockers versus other classes of drugs for hypertension

J Zhu, N Chen, M Zhou, J Guo, C Zhu… - Cochrane Database …, 2021 - cochranelibrary.com
Background This is the first update of a review published in 2010. While calcium channel
blockers (CCBs) are often recommended as a first‐line drug to treat hypertension, the effect …

The risk of myocardial infarction associated with antihypertensive drug therapies

BM Psaty, SR Heckbert, TD Koepsell, DS Siscovick… - Jama, 1995 - jamanetwork.com
Objective.—To assess the association between first myocardial infarction and the use of
antihypertensive agents. Design and Setting.—We conducted a population-based case …

Hypertension: management in adults in primary care: pharmacological update

National Collaborating Centre for Chronic Conditions … - 2006 - books.google.com
This rapid update of the NICE guideline on hypertension in primary care was undertaken
because recent large clinical outcome trials had provided new information about the …

The Valsartan Antihypertensive Long-term Use Evaluation (VALUE) trial of cardiovascular events in hypertension. Rationale and design

JMS JULIUS - Blood Pressure, 1998 - Taylor & Francis
Essential hypertension is a major Public Health issue. Although the number of treated
hypertensive patients has increased, only 25% of treated patients have their blood pressure …

Advancing management of hypertension through pharmacogenomics

JA Johnson - Annals of medicine, 2012 - Taylor & Francis
Hypertension is the most common, chronic disease in the world, and there are many
effective pharmacological agents available for its treatment. Despite the plethora of …

[HTML][HTML] IgM anti-malondialdehyde low density lipoprotein antibody levels indicate coronary heart disease and necrotic core characteristics in the Nordic Diltiazem …

VJ van den Berg, DO Haskard, A Fedorowski… - …, 2018 - thelancet.com
Abstract Background Certain immunoglobulins (Ig) are proposed to have protective
functions in atherosclerosis. Objectives We tested whether serum levels of IgG and IgM …

Genome-wide and gene-based meta-analyses identify novel loci influencing blood pressure response to hydrochlorothiazide

E Salvi, Z Wang, F Rizzi, Y Gong, CW McDonough… - …, 2017 - Am Heart Assoc
This study aimed to identify novel loci influencing the antihypertensive response to
hydrochlorothiazide monotherapy. A genome-wide meta-analysis of blood pressure (BP) …

Influence of age, sex and blood pressure on the principal endpoints of the Nordic Diltiazem (NORDIL) Study

SE Kjeldsen, T Hedner, JO Syvertsen… - Journal of …, 2002 - journals.lww.com
Background The aim of the Nordic Diltiazem (NORDIL) Study was to compare patients with
essential hypertension receiving calcium-antagonist-based treatment with diltiazem and …

Diabetes mellitus and raised serum triglyceride concentration in treated hypertension—are they of prognostic importance? Observational study

O Samuelsson, K Pennert, O Andersson, G Berglund… - Bmj, 1996 - bmj.com
Objective: To analyse whether metabolic changes during long term treatment with
antihypertensive drugs are associated with an increased risk of coronary heart disease …